Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP883484.RA3nU4Uj_6ei_1nIDFORvRWS0qxbOYR5rBwblatPjGs3A130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP883484.RA3nU4Uj_6ei_1nIDFORvRWS0qxbOYR5rBwblatPjGs3A130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP883484.RA3nU4Uj_6ei_1nIDFORvRWS0qxbOYR5rBwblatPjGs3A130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP883484.RA3nU4Uj_6ei_1nIDFORvRWS0qxbOYR5rBwblatPjGs3A130_provenance.
- NP883484.RA3nU4Uj_6ei_1nIDFORvRWS0qxbOYR5rBwblatPjGs3A130_assertion description "[Genetic and pharmacological studies in mice revealed that elevated CD73-mediated excess renal adenosine preferentially induced A2B adenosine receptor (ADORA2B) production and that enhanced kidney ADORA2B signaling contributes to angiotensin II-induced hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP883484.RA3nU4Uj_6ei_1nIDFORvRWS0qxbOYR5rBwblatPjGs3A130_provenance.
- NP883484.RA3nU4Uj_6ei_1nIDFORvRWS0qxbOYR5rBwblatPjGs3A130_assertion evidence source_evidence_literature NP883484.RA3nU4Uj_6ei_1nIDFORvRWS0qxbOYR5rBwblatPjGs3A130_provenance.
- NP883484.RA3nU4Uj_6ei_1nIDFORvRWS0qxbOYR5rBwblatPjGs3A130_assertion SIO_000772 23584256 NP883484.RA3nU4Uj_6ei_1nIDFORvRWS0qxbOYR5rBwblatPjGs3A130_provenance.
- NP883484.RA3nU4Uj_6ei_1nIDFORvRWS0qxbOYR5rBwblatPjGs3A130_assertion wasDerivedFrom befree-20140225 NP883484.RA3nU4Uj_6ei_1nIDFORvRWS0qxbOYR5rBwblatPjGs3A130_provenance.
- NP883484.RA3nU4Uj_6ei_1nIDFORvRWS0qxbOYR5rBwblatPjGs3A130_assertion wasGeneratedBy ECO_0000203 NP883484.RA3nU4Uj_6ei_1nIDFORvRWS0qxbOYR5rBwblatPjGs3A130_provenance.
- befree-20140225 importedOn "2014-02-25" NP883484.RA3nU4Uj_6ei_1nIDFORvRWS0qxbOYR5rBwblatPjGs3A130_provenance.